Search

D. Margaret M. Seaman

Examiner (ID: 10494, Phone: (571)272-0694 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1612, 1625, 1203, 1621
Total Applications
3129
Issued Applications
2302
Pending Applications
276
Abandoned Applications
578

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18878972 [patent_doc_number] => 20240002341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-04 [patent_title] => METHODS OF MAKING NICOTINIC ACID DERIVATIVES [patent_app_type] => utility [patent_app_number] => 18/032842 [patent_app_country] => US [patent_app_date] => 2021-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8615 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032842 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/032842
METHODS OF MAKING NICOTINIC ACID DERIVATIVES Oct 21, 2021 Pending
Array ( [id] => 18861764 [patent_doc_number] => 20230416199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => INHIBITORS OF AMINO ACID TRANSPORT [patent_app_type] => utility [patent_app_number] => 18/249142 [patent_app_country] => US [patent_app_date] => 2021-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23085 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18249142 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/249142
INHIBITORS OF AMINO ACID TRANSPORT Oct 21, 2021 Pending
Array ( [id] => 19629606 [patent_doc_number] => 20240408055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => USE OF ANISOMELIC ACID IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR INHIBITING INFECTION AND REPLICATION OF SARS-COV-2 AND VARIANTS [patent_app_type] => utility [patent_app_number] => 18/702340 [patent_app_country] => US [patent_app_date] => 2021-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18702340 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/702340
USE OF ANISOMELIC ACID IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR INHIBITING INFECTION AND REPLICATION OF SARS-COV-2 AND VARIANTS Oct 20, 2021 Pending
Array ( [id] => 17656969 [patent_doc_number] => 20220177434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/506447 [patent_app_country] => US [patent_app_date] => 2021-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22010 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17506447 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/506447
Modulators of mas-related G-protein receptor X2 and related products and methods Oct 19, 2021 Issued
Array ( [id] => 18808527 [patent_doc_number] => 20230382860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-30 [patent_title] => Bioactive Benzocycloheptene Analogues From Himachalenes and its Applications [patent_app_type] => utility [patent_app_number] => 18/032732 [patent_app_country] => US [patent_app_date] => 2019-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10016 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18032732 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/032732
Bioactive benzocycloheptene analogues from himachalenes and its applications Oct 18, 2021 Issued
Array ( [id] => 17761392 [patent_doc_number] => 20220235004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => PARA ACYL SUBSTITUTED DIAZACYCLOHEXENE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/499728 [patent_app_country] => US [patent_app_date] => 2021-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3619 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499728 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/499728
Para acyl substituted diazacyclohexene derivatives Oct 11, 2021 Issued
Array ( [id] => 17368232 [patent_doc_number] => 20220023284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds [patent_app_type] => utility [patent_app_number] => 17/497201 [patent_app_country] => US [patent_app_date] => 2021-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10541 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17497201 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/497201
Processes for Preparing Quinoline Compounds and Pharmaceutical Compositions Containing Such Compounds Oct 7, 2021 Abandoned
Array ( [id] => 19034024 [patent_doc_number] => 20240083839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS [patent_app_type] => utility [patent_app_number] => 18/030686 [patent_app_country] => US [patent_app_date] => 2021-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43448 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18030686 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/030686
COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES AND DISORDERS Oct 5, 2021 Pending
Array ( [id] => 17369855 [patent_doc_number] => 20220024907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY [patent_app_type] => utility [patent_app_number] => 17/494370 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52308 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494370 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/494370
COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Oct 4, 2021 Abandoned
Array ( [id] => 17503268 [patent_doc_number] => 20220096370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => HIGH PENETRATION COMPOSITION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/493321 [patent_app_country] => US [patent_app_date] => 2021-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11091 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493321 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/493321
HIGH PENETRATION COMPOSITION AND USES THEREOF Oct 3, 2021 Abandoned
Array ( [id] => 18725686 [patent_doc_number] => 20230339862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => NOVEL DIBENZOACRIDINIUM DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/044829 [patent_app_country] => US [patent_app_date] => 2021-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10129 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 163 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18044829 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/044829
NOVEL DIBENZOACRIDINIUM DERIVATIVES, THEIR PROCESS OF PREPARATION AND THEIR USE FOR TREATING VIRAL INFECTIONS Sep 13, 2021 Pending
Array ( [id] => 17563082 [patent_doc_number] => 20220127231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => PROCESS FOR THE PREPARTION OF AMIFAMPRIDINE PHOSPHATE [patent_app_type] => utility [patent_app_number] => 17/474087 [patent_app_country] => US [patent_app_date] => 2021-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3954 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17474087 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/474087
PROCESS FOR THE PREPARTION OF AMIFAMPRIDINE PHOSPHATE Sep 13, 2021 Abandoned
Array ( [id] => 18770756 [patent_doc_number] => 20230365540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-16 [patent_title] => SMALL MOLECULE INHIBITORS OF ENPP1 [patent_app_type] => utility [patent_app_number] => 18/025487 [patent_app_country] => US [patent_app_date] => 2021-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17737 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025487 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025487
SMALL MOLECULE INHIBITORS OF ENPP1 Sep 8, 2021 Abandoned
Array ( [id] => 18692442 [patent_doc_number] => 20230322682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF (S)-5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)-1-(1,1,1-TRIFLUOROPROPANE-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE [patent_app_type] => utility [patent_app_number] => 18/043971 [patent_app_country] => US [patent_app_date] => 2021-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12572 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043971 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/043971
PROCESSES AND INTERMEDIATES FOR THE PREPARATION OF (S)-5-AMINO-3-(4-((5-FLUORO-2-METHOXYBENZAMIDO)METHYL)PHENYL)-1-(1,1,1-TRIFLUOROPROPANE-2-YL)-1H-PYRAZOLE-4-CARBOXAMIDE Sep 8, 2021 Pending
Array ( [id] => 20578374 [patent_doc_number] => 12570616 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-10 [patent_title] => Therapeutic compounds [patent_app_type] => utility [patent_app_number] => 18/023995 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1195 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023995 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/023995
Therapeutic compounds Sep 7, 2021 Issued
Array ( [id] => 18739470 [patent_doc_number] => 20230348394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-02 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHIES [patent_app_type] => utility [patent_app_number] => 18/025747 [patent_app_country] => US [patent_app_date] => 2021-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21643 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025747 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/025747
COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHIES Sep 7, 2021 Pending
Array ( [id] => 17687610 [patent_doc_number] => 20220194902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => Method of Preparing Fluorine-18 Labeled Cabozantinib and Its Analogs [patent_app_type] => utility [patent_app_number] => 17/466328 [patent_app_country] => US [patent_app_date] => 2021-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11341 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466328 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/466328
Method of Preparing Fluorine-18 Labeled Cabozantinib and Its Analogs Sep 2, 2021 Abandoned
Array ( [id] => 18254252 [patent_doc_number] => 20230081291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => QUINOLINE cGAS ANTAGONIST COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/446951 [patent_app_country] => US [patent_app_date] => 2021-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17446951 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/446951
Quinoline cGAS antagonist compounds Sep 2, 2021 Issued
Array ( [id] => 17314432 [patent_doc_number] => 20210403480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => SELECTIVE ESTROGEN RECEPTOR DEGRADERS [patent_app_type] => utility [patent_app_number] => 17/465066 [patent_app_country] => US [patent_app_date] => 2021-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17622 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17465066 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/465066
Selective estrogen receptor degraders Sep 1, 2021 Issued
Array ( [id] => 20730225 [patent_doc_number] => 12637473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-05-26 [patent_title] => MDM2 protein degraders [patent_app_type] => utility [patent_app_number] => 17/462355 [patent_app_country] => US [patent_app_date] => 2021-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 37676 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 341 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17462355 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/462355
MDM2 protein degraders Aug 30, 2021 Issued
Menu